BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21129063)

  • 1. Molecular diagnostics in embryonal brain tumors.
    Eberhart CG
    Brain Pathol; 2011 Jan; 21(1):96-104. PubMed ID: 21129063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnostics of CNS embryonal tumors.
    Pfister SM; Korshunov A; Kool M; Hasselblatt M; Eberhart C; Taylor MD
    Acta Neuropathol; 2010 Nov; 120(5):553-66. PubMed ID: 20882288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonal tumors in the WHO CNS5 classification: A Review.
    Gianno F; Miele E; Antonelli M; Giangaspero F
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Beckmann PJ; Larson JD; Larsson AT; Ostergaard JP; Wagner S; Rahrmann EP; Shamsan GA; Otto GM; Williams RL; Wang J; Lee C; Tschida BR; Das P; Dubuc AM; Moriarity BS; Picard D; Wu X; Rodriguez FJ; Rosemarie Q; Krebs RD; Molan AM; Demer AM; Frees MM; Rizzardi AE; Schmechel SC; Eberhart CG; Jenkins RB; Wechsler-Reya RJ; Odde DJ; Huang A; Taylor MD; Sarver AL; Largaespada DA
    Cancer Res; 2019 Mar; 79(5):905-917. PubMed ID: 30674530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
    Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
    J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primitive neuroectodermal tumors/medulloblastoma.
    Weil MD
    Curr Neurol Neurosci Rep; 2002 May; 2(3):205-9. PubMed ID: 11936998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of somatostatin receptors, P44/42 MAPK, and mTOR activation in medulloblastomas and primitive neuroectodermal tumors.
    Johnson MD; O'Connell MJ; Silberstein H; Korones D
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):532-8. PubMed ID: 23455179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
    Frühwald MC; O'Dorisio MS; Rush LJ; Reiter JL; Smiraglia DJ; Wenger G; Costello JF; White PS; Krahe R; Brodeur GM; Plass C
    J Med Genet; 2000 Jul; 37(7):501-9. PubMed ID: 10882752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
    Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
    Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
    Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
    von Hoff K; Haberler C; Schmitt-Hoffner F; Schepke E; de Rojas T; Jacobs S; Zapotocky M; Sumerauer D; Perek-Polnik M; Dufour C; van Vuurden D; Slavc I; Gojo J; Pickles JC; Gerber NU; Massimino M; Gil-da-Costa MJ; Garami M; Kumirova E; Sehested A; Scheie D; Cruz O; Moreno L; Cho J; Zeller B; Bovenschen N; Grotzer M; Alderete D; Snuderl M; Zheludkova O; Golanov A; Okonechnikov K; Mynarek M; Juhnke BO; Rutkowski S; Schüller U; Pizer B; von Zezschwitz B; Kwiecien R; Wechsung M; Konietschke F; Hwang EI; Sturm D; Pfister SM; von Deimling A; Rushing EJ; Ryzhova M; Hauser P; Łastowska M; Wesseling P; Giangaspero F; Hawkins C; Figarella-Branger D; Eberhart C; Burger P; Gessi M; Korshunov A; Jacques TS; Capper D; Pietsch T; Kool M
    Neuro Oncol; 2021 Sep; 23(9):1597-1611. PubMed ID: 34077956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
    Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
    Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma/Primitive neuroectodermal tumor and germ cell tumors: the uncommon but potentially curable primary brain tumors.
    Samkari A; Hwang E; Packer RJ
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):881-95. PubMed ID: 22794288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).
    Rogers HA; Miller S; Lowe J; Brundler MA; Coyle B; Grundy RG
    Br J Cancer; 2009 Apr; 100(8):1292-302. PubMed ID: 19293793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropathology of medulloblastomas and other CNS embryonal tumors : Precision diagnostics through the integration of genetic markers].
    Pietsch T
    Pathologe; 2019 Mar; 40(2):140-147. PubMed ID: 30790012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
    Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
    J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.
    Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A
    Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.
    Biegel JA; Fogelgren B; Zhou JY; James CD; Janss AJ; Allen JC; Zagzag D; Raffel C; Rorke LB
    Clin Cancer Res; 2000 Jul; 6(7):2759-63. PubMed ID: 10914721
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.